PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23649895-11	2013	NAG and its analogue and orphan drug N-carbamoyl-l-glutamate, protected human CPS1 against proteolytic and thermal inactivation in the presence of MgATP, raising hopes of treating CPS1D by chemical chaperoning with N-carbamoyl-l-glutamate.	N-carbamylglutamate	215-238	N-acetyl-alpha-glucosaminidase	Homo sapiens	0-3	
29055942-2	2017	Oral administration of N-carbamoylglutamate (NCG), a synthetic analog of N-acetylglutamate (NAG), successfully decreases plasma ammonia levels in the affected children.	N-carbamylglutamate	23-43	N-acetyl-alpha-glucosaminidase	Homo sapiens	92-95	
29055942-2	2017	Oral administration of N-carbamoylglutamate (NCG), a synthetic analog of N-acetylglutamate (NAG), successfully decreases plasma ammonia levels in the affected children.	N-carbamylglutamate	45-48	N-acetyl-alpha-glucosaminidase	Homo sapiens	92-95	
26059772-6	2015	Patients with NAG affinity-decreasing mutations might benefit from NAG site saturation therapy with N-carbamyl-L-glutamate (a registered drug, the analog of NAG).	N-carbamylglutamate	100-122	N-acetyl-alpha-glucosaminidase	Homo sapiens	14-17	
26059772-6	2015	Patients with NAG affinity-decreasing mutations might benefit from NAG site saturation therapy with N-carbamyl-L-glutamate (a registered drug, the analog of NAG).	N-carbamylglutamate	100-122	N-acetyl-alpha-glucosaminidase	Homo sapiens	67-70	
26059772-6	2015	Patients with NAG affinity-decreasing mutations might benefit from NAG site saturation therapy with N-carbamyl-L-glutamate (a registered drug, the analog of NAG).	N-carbamylglutamate	100-122	N-acetyl-alpha-glucosaminidase	Homo sapiens	67-70	
27570737-3	2016	Although NAGS deficiency is the rarest urea cycle disorder, it is the only one that can be specifically and effectively treated by a drug, N-carbamylglutamate, a stable structural analogous of NAG that activates CPS1.	N-carbamylglutamate	139-158	N-acetyl-alpha-glucosaminidase	Homo sapiens	9-12	
18338235-2	2008	N-Carbamylglutamate, a NAG analogue, has been reported to correct hyperammonaemia in neonates with organic acidaemias.	N-carbamylglutamate	0-19	N-acetyl-alpha-glucosaminidase	Homo sapiens	23-26	
20303810-9	2010	For either condition, N-carbamylglutamate (NCG), a stable functional analog of NAG, was found to either restore or improve the deficient urea-cycle function.	N-carbamylglutamate	22-41	N-acetyl-alpha-glucosaminidase	Homo sapiens	79-82	
15050968-10	2004	A structural analog of NAG, carbamylglutamate, has been shown to bind and activate CPSI, and several patients have been reported to respond favorably to this drug (Carbaglu).	N-carbamylglutamate	28-45	N-acetyl-alpha-glucosaminidase	Homo sapiens	23-26